Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy: Results of a prospective, two-centre registry

Netherlands Heart Journal

Volumn 18, Issue 5, 2010, Pages 230-235

  Przybylski, A ^a   Derejko, P ^a   Kwasniewski W ^b   Urbanczyk Swic D ^b   Zakrzewska, J ^a   Orszulak, W ^b   Orczykowski, M ^a   Filipecki, A ^b   Szumowski, L ^a   Walczak, F ^a   Trusz Gluza, M ^b  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Adverse effects; Defibrillators; Drug therapy; Pacemaker; Platelet aggregation inhibitors; Postoperative complications

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BLEEDING; BLOOD TRANSFUSION; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE REGISTRY; ECCHYMOSIS; FEMALE; HEART FAILURE; HEMATOMA; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT; SINUS NODE DISEASE; SUBCUTANEOUS HEMORRHAGE; TREND STUDY;

EID: 77953273573     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03091768     Document Type: Article

References (17)

1. Jamula E, Douketis JD, Schulman S Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide. J Thromb Haemost. 2008; 6: 1615-1621.
2. Wiegand UK, Le Jeune D, Boguschewski F, Bonnemeier H, Eberhardt F, Schunkert H, et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest. 2004;126:1177-1186.
3. Marquie C, De Geeter G, Klug D, Kouakam C, Brigadeau F, Ja-bourek O, Trillot N, et al. Post-operative use of heparin increases morbidity of pacemaker implantation. Europace. 2006; 8: 283-287.
4. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. European Society of Cardiology. Percutaneous coronary interventions. Guidelines of the European Society of Cardiology-ESC. Kardiol Pol. 2005; 63: 265-320.
5. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, et al. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007; 28: 1598-660.
6. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008; 29: 2909-45.
7. King SB III, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO. 2007 focused update of the ACC/AHA/ SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines: (2007 Writing Group to Review New Evidence and Update them 2005 ACC/AHA/SCAI Guideline Update for Percutaneous Coronary Intervention). Circulation. 2008; 117: 261-95.
8. Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Ma- gid DJ, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006; 166: 1842-7.
9. Yende S, Wunderink RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med. 2001; 29: 2271-2275.
10. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000; 35: 1288-1294.
11. Ernst A, Eberhardt R, Wahidi M, Becker HD, Herth FJ. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest. 2006; 129: 734-737.
12. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, et al. Guidelines for cardiac pacing and cardiac resynchroni-zation therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Europace. 2007; 9: 959-998.
13. Pickard AS, Becker RC, Schumock GT, Frye CB. Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting. Pharmacotherapy. 2008; 28: 376-392.
14. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006; 8: 746-837.
15. Robichaux R, Jennings J; Osorio J; Doppalapudi H, McEl-derry T, Epstein A, et al. Antiplatelet Effect on Pocket Hematoma Rate in ICD Implantation. Circulation. 2008; 118: 987-988.
16. Mahapatra S, Bybee KA, Bunch TJ, Espinosa RE, Sinak LJ, McGoon MD, et al. Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart Rhythm. 2005; 2: 907-911.
17. Sterlinski M, Przybylski A, Maciag A, Syska P, Pytkowski M, Lewandowski M, et al. Subacute cardiac perforations associated with active fixation leads. Europace. 2009; 11: 206-212.